1) Durst M, Gissmann L, Ikenberg H, et al. : A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA, 80 : 3812-3815, 1983.
2) Boshart M, Gissmann L, Ikenberg H, et al. : A new type of papillomavirus DNA its presensce in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J, 3 : 1151-1157, 1984.
3) Stanley M : Immune responces to human papillomavirus. Vaccine, 24 (Suppl.1) : S16-S22, 2006.
4) Viscidi RP, Schiffman M, Hildesheim A, et al. : Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection : results from a population-based study in Costa Rica. Cancer Epidemiol Biomarkers Prey, 13 : 324-327, 2004.
5) Carter JJ, Koutsky LA, Hughes JP, et al. : Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis, 181 : 1911-1919, 2000.